PYSZCZYMUKA GREG (Chief Commercial Officer) received a stock award from AYTU BIOPHARMA, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/7/2025ACC: 0001437749-25-030650
Officer· Chief Commercial Officer
Since Nov 2022
+12.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
12.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
53.0%
10/3/2025
23.60K→36.10K
Total
Net shares
+12.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/3/2025 | A · Award | +12.50K | — | — | 53.0% | 23.60K | 36.10K |
| Total | +12.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported